Global Artemisunate Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Artemisunate market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Artemisunate is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Artemisunate is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Artemisunate is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Artemisunate players cover Sanofi, KPC Pharmaceuticals, Guangxi Xiancaotang Pharmaceutical, Guilin Pharmaceutical, Kerui Nanhai Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Artemisunate Industry Forecast” looks at past sales and reviews total world Artemisunate sales in 2024, providing a comprehensive analysis by region and market sector of projected Artemisunate sales for 2025 through 2031. With Artemisunate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artemisunate industry.
This Insight Report provides a comprehensive analysis of the global Artemisunate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artemisunate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artemisunate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artemisunate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artemisunate.
This report presents a comprehensive overview, market shares, and growth opportunities of Artemisunate market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Artemisunate market?
What factors are driving Artemisunate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Artemisunate market opportunities vary by end market size?
How does Artemisunate break out by Type, by Application?
The global Artemisunate market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Artemisunate is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Artemisunate is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Artemisunate is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Artemisunate players cover Sanofi, KPC Pharmaceuticals, Guangxi Xiancaotang Pharmaceutical, Guilin Pharmaceutical, Kerui Nanhai Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Artemisunate Industry Forecast” looks at past sales and reviews total world Artemisunate sales in 2024, providing a comprehensive analysis by region and market sector of projected Artemisunate sales for 2025 through 2031. With Artemisunate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artemisunate industry.
This Insight Report provides a comprehensive analysis of the global Artemisunate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artemisunate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artemisunate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artemisunate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artemisunate.
This report presents a comprehensive overview, market shares, and growth opportunities of Artemisunate market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Pharmaceutical Grade
- Industrial Grade
- Malaria Treatment
- Scientific Research
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- KPC Pharmaceuticals
- Guangxi Xiancaotang Pharmaceutical
- Guilin Pharmaceutical
- Kerui Nanhai Pharmaceutical
- Shanghai Natural Bio-engineering Co
- Novanat Bioresource
- Botanical Extracts EPZ Ltd
What is the 10-year outlook for the global Artemisunate market?
What factors are driving Artemisunate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Artemisunate market opportunities vary by end market size?
How does Artemisunate break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artemisunate Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Artemisunate by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Artemisunate by Country/Region, 2020, 2024 & 2031
2.2 Artemisunate Segment by Type
2.2.1 Pharmaceutical Grade
2.2.2 Industrial Grade
2.3 Artemisunate Sales by Type
2.3.1 Global Artemisunate Sales Market Share by Type (2020-2025)
2.3.2 Global Artemisunate Revenue and Market Share by Type (2020-2025)
2.3.3 Global Artemisunate Sale Price by Type (2020-2025)
2.4 Artemisunate Segment by Application
2.4.1 Malaria Treatment
2.4.2 Scientific Research
2.4.3 Others
2.5 Artemisunate Sales by Application
2.5.1 Global Artemisunate Sale Market Share by Application (2020-2025)
2.5.2 Global Artemisunate Revenue and Market Share by Application (2020-2025)
2.5.3 Global Artemisunate Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Artemisunate Breakdown Data by Company
3.1.1 Global Artemisunate Annual Sales by Company (2020-2025)
3.1.2 Global Artemisunate Sales Market Share by Company (2020-2025)
3.2 Global Artemisunate Annual Revenue by Company (2020-2025)
3.2.1 Global Artemisunate Revenue by Company (2020-2025)
3.2.2 Global Artemisunate Revenue Market Share by Company (2020-2025)
3.3 Global Artemisunate Sale Price by Company
3.4 Key Manufacturers Artemisunate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artemisunate Product Location Distribution
3.4.2 Players Artemisunate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ARTEMISUNATE BY GEOGRAPHIC REGION
4.1 World Historic Artemisunate Market Size by Geographic Region (2020-2025)
4.1.1 Global Artemisunate Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Artemisunate Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Artemisunate Market Size by Country/Region (2020-2025)
4.2.1 Global Artemisunate Annual Sales by Country/Region (2020-2025)
4.2.2 Global Artemisunate Annual Revenue by Country/Region (2020-2025)
4.3 Americas Artemisunate Sales Growth
4.4 APAC Artemisunate Sales Growth
4.5 Europe Artemisunate Sales Growth
4.6 Middle East & Africa Artemisunate Sales Growth
5 AMERICAS
5.1 Americas Artemisunate Sales by Country
5.1.1 Americas Artemisunate Sales by Country (2020-2025)
5.1.2 Americas Artemisunate Revenue by Country (2020-2025)
5.2 Americas Artemisunate Sales by Type (2020-2025)
5.3 Americas Artemisunate Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artemisunate Sales by Region
6.1.1 APAC Artemisunate Sales by Region (2020-2025)
6.1.2 APAC Artemisunate Revenue by Region (2020-2025)
6.2 APAC Artemisunate Sales by Type (2020-2025)
6.3 APAC Artemisunate Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Artemisunate by Country
7.1.1 Europe Artemisunate Sales by Country (2020-2025)
7.1.2 Europe Artemisunate Revenue by Country (2020-2025)
7.2 Europe Artemisunate Sales by Type (2020-2025)
7.3 Europe Artemisunate Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artemisunate by Country
8.1.1 Middle East & Africa Artemisunate Sales by Country (2020-2025)
8.1.2 Middle East & Africa Artemisunate Revenue by Country (2020-2025)
8.2 Middle East & Africa Artemisunate Sales by Type (2020-2025)
8.3 Middle East & Africa Artemisunate Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artemisunate
10.3 Manufacturing Process Analysis of Artemisunate
10.4 Industry Chain Structure of Artemisunate
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artemisunate Distributors
11.3 Artemisunate Customer
12 WORLD FORECAST REVIEW FOR ARTEMISUNATE BY GEOGRAPHIC REGION
12.1 Global Artemisunate Market Size Forecast by Region
12.1.1 Global Artemisunate Forecast by Region (2026-2031)
12.1.2 Global Artemisunate Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Artemisunate Forecast by Type (2026-2031)
12.7 Global Artemisunate Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Artemisunate Product Portfolios and Specifications
13.1.3 Sanofi Artemisunate Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 KPC Pharmaceuticals
13.2.1 KPC Pharmaceuticals Company Information
13.2.2 KPC Pharmaceuticals Artemisunate Product Portfolios and Specifications
13.2.3 KPC Pharmaceuticals Artemisunate Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 KPC Pharmaceuticals Main Business Overview
13.2.5 KPC Pharmaceuticals Latest Developments
13.3 Guangxi Xiancaotang Pharmaceutical
13.3.1 Guangxi Xiancaotang Pharmaceutical Company Information
13.3.2 Guangxi Xiancaotang Pharmaceutical Artemisunate Product Portfolios and Specifications
13.3.3 Guangxi Xiancaotang Pharmaceutical Artemisunate Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Guangxi Xiancaotang Pharmaceutical Main Business Overview
13.3.5 Guangxi Xiancaotang Pharmaceutical Latest Developments
13.4 Guilin Pharmaceutical
13.4.1 Guilin Pharmaceutical Company Information
13.4.2 Guilin Pharmaceutical Artemisunate Product Portfolios and Specifications
13.4.3 Guilin Pharmaceutical Artemisunate Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Guilin Pharmaceutical Main Business Overview
13.4.5 Guilin Pharmaceutical Latest Developments
13.5 Kerui Nanhai Pharmaceutical
13.5.1 Kerui Nanhai Pharmaceutical Company Information
13.5.2 Kerui Nanhai Pharmaceutical Artemisunate Product Portfolios and Specifications
13.5.3 Kerui Nanhai Pharmaceutical Artemisunate Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Kerui Nanhai Pharmaceutical Main Business Overview
13.5.5 Kerui Nanhai Pharmaceutical Latest Developments
13.6 Shanghai Natural Bio-engineering Co
13.6.1 Shanghai Natural Bio-engineering Co Company Information
13.6.2 Shanghai Natural Bio-engineering Co Artemisunate Product Portfolios and Specifications
13.6.3 Shanghai Natural Bio-engineering Co Artemisunate Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Shanghai Natural Bio-engineering Co Main Business Overview
13.6.5 Shanghai Natural Bio-engineering Co Latest Developments
13.7 Novanat Bioresource
13.7.1 Novanat Bioresource Company Information
13.7.2 Novanat Bioresource Artemisunate Product Portfolios and Specifications
13.7.3 Novanat Bioresource Artemisunate Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Novanat Bioresource Main Business Overview
13.7.5 Novanat Bioresource Latest Developments
13.8 Botanical Extracts EPZ Ltd
13.8.1 Botanical Extracts EPZ Ltd Company Information
13.8.2 Botanical Extracts EPZ Ltd Artemisunate Product Portfolios and Specifications
13.8.3 Botanical Extracts EPZ Ltd Artemisunate Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Botanical Extracts EPZ Ltd Main Business Overview
13.8.5 Botanical Extracts EPZ Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Artemisunate Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Artemisunate Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Pharmaceutical Grade
Table 4. Major Players of Industrial Grade
Table 5. Global Artemisunate Sales byType (2020-2025) & (MT)
Table 6. Global Artemisunate Sales Market Share byType (2020-2025)
Table 7. Global Artemisunate Revenue byType (2020-2025) & ($ million)
Table 8. Global Artemisunate Revenue Market Share byType (2020-2025)
Table 9. Global Artemisunate Sale Price byType (2020-2025) & (USD/MT)
Table 10. Global Artemisunate Sale by Application (2020-2025) & (MT)
Table 11. Global Artemisunate Sale Market Share by Application (2020-2025)
Table 12. Global Artemisunate Revenue by Application (2020-2025) & ($ million)
Table 13. Global Artemisunate Revenue Market Share by Application (2020-2025)
Table 14. Global Artemisunate Sale Price by Application (2020-2025) & (USD/MT)
Table 15. Global Artemisunate Sales by Company (2020-2025) & (MT)
Table 16. Global Artemisunate Sales Market Share by Company (2020-2025)
Table 17. Global Artemisunate Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Artemisunate Revenue Market Share by Company (2020-2025)
Table 19. Global Artemisunate Sale Price by Company (2020-2025) & (USD/MT)
Table 20. Key Manufacturers Artemisunate Producing Area Distribution and Sales Area
Table 21. Players Artemisunate Products Offered
Table 22. Artemisunate Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Artemisunate Sales by Geographic Region (2020-2025) & (MT)
Table 26. Global Artemisunate Sales Market Share Geographic Region (2020-2025)
Table 27. Global Artemisunate Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Artemisunate Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Artemisunate Sales by Country/Region (2020-2025) & (MT)
Table 30. Global Artemisunate Sales Market Share by Country/Region (2020-2025)
Table 31. Global Artemisunate Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Artemisunate Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Artemisunate Sales by Country (2020-2025) & (MT)
Table 34. Americas Artemisunate Sales Market Share by Country (2020-2025)
Table 35. Americas Artemisunate Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Artemisunate Sales byType (2020-2025) & (MT)
Table 37. Americas Artemisunate Sales by Application (2020-2025) & (MT)
Table 38. APAC Artemisunate Sales by Region (2020-2025) & (MT)
Table 39. APAC Artemisunate Sales Market Share by Region (2020-2025)
Table 40. APAC Artemisunate Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Artemisunate Sales byType (2020-2025) & (MT)
Table 42. APAC Artemisunate Sales by Application (2020-2025) & (MT)
Table 43. Europe Artemisunate Sales by Country (2020-2025) & (MT)
Table 44. Europe Artemisunate Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Artemisunate Sales byType (2020-2025) & (MT)
Table 46. Europe Artemisunate Sales by Application (2020-2025) & (MT)
Table 47. Middle East & Africa Artemisunate Sales by Country (2020-2025) & (MT)
Table 48. Middle East & Africa Artemisunate Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Artemisunate Sales byType (2020-2025) & (MT)
Table 50. Middle East & Africa Artemisunate Sales by Application (2020-2025) & (MT)
Table 51. Key Market Drivers & Growth Opportunities of Artemisunate
Table 52. Key Market Challenges & Risks of Artemisunate
Table 53. Key IndustryTrends of Artemisunate
Table 54. Artemisunate Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Artemisunate Distributors List
Table 57. Artemisunate Customer List
Table 58. Global Artemisunate SalesForecast by Region (2026-2031) & (MT)
Table 59. Global Artemisunate RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Artemisunate SalesForecast by Country (2026-2031) & (MT)
Table 61. Americas Artemisunate Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Artemisunate SalesForecast by Region (2026-2031) & (MT)
Table 63. APAC Artemisunate Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Artemisunate SalesForecast by Country (2026-2031) & (MT)
Table 65. Europe Artemisunate RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Artemisunate SalesForecast by Country (2026-2031) & (MT)
Table 67. Middle East & Africa Artemisunate RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Artemisunate SalesForecast byType (2026-2031) & (MT)
Table 69. Global Artemisunate RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Artemisunate SalesForecast by Application (2026-2031) & (MT)
Table 71. Global Artemisunate RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Sanofi Basic Information, Artemisunate Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Artemisunate Product Portfolios and Specifications
Table 74. Sanofi Artemisunate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Sanofi Main Business
Table 76. Sanofi Latest Developments
Table 77. KPC Pharmaceuticals Basic Information, Artemisunate Manufacturing Base, Sales Area and Its Competitors
Table 78. KPC Pharmaceuticals Artemisunate Product Portfolios and Specifications
Table 79. KPC Pharmaceuticals Artemisunate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. KPC Pharmaceuticals Main Business
Table 81. KPC Pharmaceuticals Latest Developments
Table 82. Guangxi Xiancaotang Pharmaceutical Basic Information, Artemisunate Manufacturing Base, Sales Area and Its Competitors
Table 83. Guangxi Xiancaotang Pharmaceutical Artemisunate Product Portfolios and Specifications
Table 84. Guangxi Xiancaotang Pharmaceutical Artemisunate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Guangxi Xiancaotang Pharmaceutical Main Business
Table 86. Guangxi Xiancaotang Pharmaceutical Latest Developments
Table 87. Guilin Pharmaceutical Basic Information, Artemisunate Manufacturing Base, Sales Area and Its Competitors
Table 88. Guilin Pharmaceutical Artemisunate Product Portfolios and Specifications
Table 89. Guilin Pharmaceutical Artemisunate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Guilin Pharmaceutical Main Business
Table 91. Guilin Pharmaceutical Latest Developments
Table 92. Kerui Nanhai Pharmaceutical Basic Information, Artemisunate Manufacturing Base, Sales Area and Its Competitors
Table 93. Kerui Nanhai Pharmaceutical Artemisunate Product Portfolios and Specifications
Table 94. Kerui Nanhai Pharmaceutical Artemisunate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95. Kerui Nanhai Pharmaceutical Main Business
Table 96. Kerui Nanhai Pharmaceutical Latest Developments
Table 97. Shanghai Natural Bio-engineering Co Basic Information, Artemisunate Manufacturing Base, Sales Area and Its Competitors
Table 98. Shanghai Natural Bio-engineering Co Artemisunate Product Portfolios and Specifications
Table 99. Shanghai Natural Bio-engineering Co Artemisunate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Shanghai Natural Bio-engineering Co Main Business
Table 101. Shanghai Natural Bio-engineering Co Latest Developments
Table 102. Novanat Bioresource Basic Information, Artemisunate Manufacturing Base, Sales Area and Its Competitors
Table 103. Novanat Bioresource Artemisunate Product Portfolios and Specifications
Table 104. Novanat Bioresource Artemisunate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 105. Novanat Bioresource Main Business
Table 106. Novanat Bioresource Latest Developments
Table 107. Botanical Extracts EPZ Ltd Basic Information, Artemisunate Manufacturing Base, Sales Area and Its Competitors
Table 108. Botanical Extracts EPZ Ltd Artemisunate Product Portfolios and Specifications
Table 109. Botanical Extracts EPZ Ltd Artemisunate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Botanical Extracts EPZ Ltd Main Business
Table 111. Botanical Extracts EPZ Ltd Latest Developments
LIST OFFIGURES
Figure 1. Picture of Artemisunate
Figure 2. Artemisunate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artemisunate Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Artemisunate Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Artemisunate Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Artemisunate Sales Market Share by Country/Region (2024)
Figure 10. Artemisunate Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Pharmaceutical Grade
Figure 12. Product Picture of Industrial Grade
Figure 13. Global Artemisunate Sales Market Share byType in 2025
Figure 14. Global Artemisunate Revenue Market Share byType (2020-2025)
Figure 15. Artemisunate Consumed in MalariaTreatment
Figure 16. Global Artemisunate Market: MalariaTreatment (2020-2025) & (MT)
Figure 17. Artemisunate Consumed in Scientific Research
Figure 18. Global Artemisunate Market: Scientific Research (2020-2025) & (MT)
Figure 19. Artemisunate Consumed in Others
Figure 20. Global Artemisunate Market: Others (2020-2025) & (MT)
Figure 21. Global Artemisunate Sale Market Share by Application (2024)
Figure 22. Global Artemisunate Revenue Market Share by Application in 2025
Figure 23. Artemisunate Sales by Company in 2025 (MT)
Figure 24. Global Artemisunate Sales Market Share by Company in 2025
Figure 25. Artemisunate Revenue by Company in 2025 ($ millions)
Figure 26. Global Artemisunate Revenue Market Share by Company in 2025
Figure 27. Global Artemisunate Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Artemisunate Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Artemisunate Sales 2020-2025 (MT)
Figure 30. Americas Artemisunate Revenue 2020-2025 ($ millions)
Figure 31. APAC Artemisunate Sales 2020-2025 (MT)
Figure 32. APAC Artemisunate Revenue 2020-2025 ($ millions)
Figure 33. Europe Artemisunate Sales 2020-2025 (MT)
Figure 34. Europe Artemisunate Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Artemisunate Sales 2020-2025 (MT)
Figure 36. Middle East & Africa Artemisunate Revenue 2020-2025 ($ millions)
Figure 37. Americas Artemisunate Sales Market Share by Country in 2025
Figure 38. Americas Artemisunate Revenue Market Share by Country (2020-2025)
Figure 39. Americas Artemisunate Sales Market Share byType (2020-2025)
Figure 40. Americas Artemisunate Sales Market Share by Application (2020-2025)
Figure 41. United States Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Artemisunate Sales Market Share by Region in 2025
Figure 46. APAC Artemisunate Revenue Market Share by Region (2020-2025)
Figure 47. APAC Artemisunate Sales Market Share byType (2020-2025)
Figure 48. APAC Artemisunate Sales Market Share by Application (2020-2025)
Figure 49. China Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 53. India Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Artemisunate Sales Market Share by Country in 2025
Figure 57. Europe Artemisunate Revenue Market Share by Country (2020-2025)
Figure 58. Europe Artemisunate Sales Market Share byType (2020-2025)
Figure 59. Europe Artemisunate Sales Market Share by Application (2020-2025)
Figure 60. Germany Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 61.France Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Artemisunate Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Artemisunate Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Artemisunate Sales Market Share by Application (2020-2025)
Figure 68. Egypt Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Artemisunate in 2025
Figure 74. Manufacturing Process Analysis of Artemisunate
Figure 75. Industry Chain Structure of Artemisunate
Figure 76. Channels of Distribution
Figure 77. Global Artemisunate Sales MarketForecast by Region (2026-2031)
Figure 78. Global Artemisunate Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Artemisunate Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Artemisunate Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Artemisunate Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Artemisunate Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artemisunate Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Artemisunate by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Artemisunate by Country/Region, 2020, 2024 & 2031
2.2 Artemisunate Segment by Type
2.2.1 Pharmaceutical Grade
2.2.2 Industrial Grade
2.3 Artemisunate Sales by Type
2.3.1 Global Artemisunate Sales Market Share by Type (2020-2025)
2.3.2 Global Artemisunate Revenue and Market Share by Type (2020-2025)
2.3.3 Global Artemisunate Sale Price by Type (2020-2025)
2.4 Artemisunate Segment by Application
2.4.1 Malaria Treatment
2.4.2 Scientific Research
2.4.3 Others
2.5 Artemisunate Sales by Application
2.5.1 Global Artemisunate Sale Market Share by Application (2020-2025)
2.5.2 Global Artemisunate Revenue and Market Share by Application (2020-2025)
2.5.3 Global Artemisunate Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Artemisunate Breakdown Data by Company
3.1.1 Global Artemisunate Annual Sales by Company (2020-2025)
3.1.2 Global Artemisunate Sales Market Share by Company (2020-2025)
3.2 Global Artemisunate Annual Revenue by Company (2020-2025)
3.2.1 Global Artemisunate Revenue by Company (2020-2025)
3.2.2 Global Artemisunate Revenue Market Share by Company (2020-2025)
3.3 Global Artemisunate Sale Price by Company
3.4 Key Manufacturers Artemisunate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artemisunate Product Location Distribution
3.4.2 Players Artemisunate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ARTEMISUNATE BY GEOGRAPHIC REGION
4.1 World Historic Artemisunate Market Size by Geographic Region (2020-2025)
4.1.1 Global Artemisunate Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Artemisunate Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Artemisunate Market Size by Country/Region (2020-2025)
4.2.1 Global Artemisunate Annual Sales by Country/Region (2020-2025)
4.2.2 Global Artemisunate Annual Revenue by Country/Region (2020-2025)
4.3 Americas Artemisunate Sales Growth
4.4 APAC Artemisunate Sales Growth
4.5 Europe Artemisunate Sales Growth
4.6 Middle East & Africa Artemisunate Sales Growth
5 AMERICAS
5.1 Americas Artemisunate Sales by Country
5.1.1 Americas Artemisunate Sales by Country (2020-2025)
5.1.2 Americas Artemisunate Revenue by Country (2020-2025)
5.2 Americas Artemisunate Sales by Type (2020-2025)
5.3 Americas Artemisunate Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artemisunate Sales by Region
6.1.1 APAC Artemisunate Sales by Region (2020-2025)
6.1.2 APAC Artemisunate Revenue by Region (2020-2025)
6.2 APAC Artemisunate Sales by Type (2020-2025)
6.3 APAC Artemisunate Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Artemisunate by Country
7.1.1 Europe Artemisunate Sales by Country (2020-2025)
7.1.2 Europe Artemisunate Revenue by Country (2020-2025)
7.2 Europe Artemisunate Sales by Type (2020-2025)
7.3 Europe Artemisunate Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artemisunate by Country
8.1.1 Middle East & Africa Artemisunate Sales by Country (2020-2025)
8.1.2 Middle East & Africa Artemisunate Revenue by Country (2020-2025)
8.2 Middle East & Africa Artemisunate Sales by Type (2020-2025)
8.3 Middle East & Africa Artemisunate Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artemisunate
10.3 Manufacturing Process Analysis of Artemisunate
10.4 Industry Chain Structure of Artemisunate
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artemisunate Distributors
11.3 Artemisunate Customer
12 WORLD FORECAST REVIEW FOR ARTEMISUNATE BY GEOGRAPHIC REGION
12.1 Global Artemisunate Market Size Forecast by Region
12.1.1 Global Artemisunate Forecast by Region (2026-2031)
12.1.2 Global Artemisunate Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Artemisunate Forecast by Type (2026-2031)
12.7 Global Artemisunate Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Artemisunate Product Portfolios and Specifications
13.1.3 Sanofi Artemisunate Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 KPC Pharmaceuticals
13.2.1 KPC Pharmaceuticals Company Information
13.2.2 KPC Pharmaceuticals Artemisunate Product Portfolios and Specifications
13.2.3 KPC Pharmaceuticals Artemisunate Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 KPC Pharmaceuticals Main Business Overview
13.2.5 KPC Pharmaceuticals Latest Developments
13.3 Guangxi Xiancaotang Pharmaceutical
13.3.1 Guangxi Xiancaotang Pharmaceutical Company Information
13.3.2 Guangxi Xiancaotang Pharmaceutical Artemisunate Product Portfolios and Specifications
13.3.3 Guangxi Xiancaotang Pharmaceutical Artemisunate Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Guangxi Xiancaotang Pharmaceutical Main Business Overview
13.3.5 Guangxi Xiancaotang Pharmaceutical Latest Developments
13.4 Guilin Pharmaceutical
13.4.1 Guilin Pharmaceutical Company Information
13.4.2 Guilin Pharmaceutical Artemisunate Product Portfolios and Specifications
13.4.3 Guilin Pharmaceutical Artemisunate Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Guilin Pharmaceutical Main Business Overview
13.4.5 Guilin Pharmaceutical Latest Developments
13.5 Kerui Nanhai Pharmaceutical
13.5.1 Kerui Nanhai Pharmaceutical Company Information
13.5.2 Kerui Nanhai Pharmaceutical Artemisunate Product Portfolios and Specifications
13.5.3 Kerui Nanhai Pharmaceutical Artemisunate Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Kerui Nanhai Pharmaceutical Main Business Overview
13.5.5 Kerui Nanhai Pharmaceutical Latest Developments
13.6 Shanghai Natural Bio-engineering Co
13.6.1 Shanghai Natural Bio-engineering Co Company Information
13.6.2 Shanghai Natural Bio-engineering Co Artemisunate Product Portfolios and Specifications
13.6.3 Shanghai Natural Bio-engineering Co Artemisunate Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Shanghai Natural Bio-engineering Co Main Business Overview
13.6.5 Shanghai Natural Bio-engineering Co Latest Developments
13.7 Novanat Bioresource
13.7.1 Novanat Bioresource Company Information
13.7.2 Novanat Bioresource Artemisunate Product Portfolios and Specifications
13.7.3 Novanat Bioresource Artemisunate Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Novanat Bioresource Main Business Overview
13.7.5 Novanat Bioresource Latest Developments
13.8 Botanical Extracts EPZ Ltd
13.8.1 Botanical Extracts EPZ Ltd Company Information
13.8.2 Botanical Extracts EPZ Ltd Artemisunate Product Portfolios and Specifications
13.8.3 Botanical Extracts EPZ Ltd Artemisunate Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Botanical Extracts EPZ Ltd Main Business Overview
13.8.5 Botanical Extracts EPZ Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Artemisunate Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Artemisunate Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Pharmaceutical Grade
Table 4. Major Players of Industrial Grade
Table 5. Global Artemisunate Sales byType (2020-2025) & (MT)
Table 6. Global Artemisunate Sales Market Share byType (2020-2025)
Table 7. Global Artemisunate Revenue byType (2020-2025) & ($ million)
Table 8. Global Artemisunate Revenue Market Share byType (2020-2025)
Table 9. Global Artemisunate Sale Price byType (2020-2025) & (USD/MT)
Table 10. Global Artemisunate Sale by Application (2020-2025) & (MT)
Table 11. Global Artemisunate Sale Market Share by Application (2020-2025)
Table 12. Global Artemisunate Revenue by Application (2020-2025) & ($ million)
Table 13. Global Artemisunate Revenue Market Share by Application (2020-2025)
Table 14. Global Artemisunate Sale Price by Application (2020-2025) & (USD/MT)
Table 15. Global Artemisunate Sales by Company (2020-2025) & (MT)
Table 16. Global Artemisunate Sales Market Share by Company (2020-2025)
Table 17. Global Artemisunate Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Artemisunate Revenue Market Share by Company (2020-2025)
Table 19. Global Artemisunate Sale Price by Company (2020-2025) & (USD/MT)
Table 20. Key Manufacturers Artemisunate Producing Area Distribution and Sales Area
Table 21. Players Artemisunate Products Offered
Table 22. Artemisunate Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Artemisunate Sales by Geographic Region (2020-2025) & (MT)
Table 26. Global Artemisunate Sales Market Share Geographic Region (2020-2025)
Table 27. Global Artemisunate Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Artemisunate Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Artemisunate Sales by Country/Region (2020-2025) & (MT)
Table 30. Global Artemisunate Sales Market Share by Country/Region (2020-2025)
Table 31. Global Artemisunate Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Artemisunate Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Artemisunate Sales by Country (2020-2025) & (MT)
Table 34. Americas Artemisunate Sales Market Share by Country (2020-2025)
Table 35. Americas Artemisunate Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Artemisunate Sales byType (2020-2025) & (MT)
Table 37. Americas Artemisunate Sales by Application (2020-2025) & (MT)
Table 38. APAC Artemisunate Sales by Region (2020-2025) & (MT)
Table 39. APAC Artemisunate Sales Market Share by Region (2020-2025)
Table 40. APAC Artemisunate Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Artemisunate Sales byType (2020-2025) & (MT)
Table 42. APAC Artemisunate Sales by Application (2020-2025) & (MT)
Table 43. Europe Artemisunate Sales by Country (2020-2025) & (MT)
Table 44. Europe Artemisunate Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Artemisunate Sales byType (2020-2025) & (MT)
Table 46. Europe Artemisunate Sales by Application (2020-2025) & (MT)
Table 47. Middle East & Africa Artemisunate Sales by Country (2020-2025) & (MT)
Table 48. Middle East & Africa Artemisunate Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Artemisunate Sales byType (2020-2025) & (MT)
Table 50. Middle East & Africa Artemisunate Sales by Application (2020-2025) & (MT)
Table 51. Key Market Drivers & Growth Opportunities of Artemisunate
Table 52. Key Market Challenges & Risks of Artemisunate
Table 53. Key IndustryTrends of Artemisunate
Table 54. Artemisunate Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Artemisunate Distributors List
Table 57. Artemisunate Customer List
Table 58. Global Artemisunate SalesForecast by Region (2026-2031) & (MT)
Table 59. Global Artemisunate RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Artemisunate SalesForecast by Country (2026-2031) & (MT)
Table 61. Americas Artemisunate Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Artemisunate SalesForecast by Region (2026-2031) & (MT)
Table 63. APAC Artemisunate Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Artemisunate SalesForecast by Country (2026-2031) & (MT)
Table 65. Europe Artemisunate RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Artemisunate SalesForecast by Country (2026-2031) & (MT)
Table 67. Middle East & Africa Artemisunate RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Artemisunate SalesForecast byType (2026-2031) & (MT)
Table 69. Global Artemisunate RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Artemisunate SalesForecast by Application (2026-2031) & (MT)
Table 71. Global Artemisunate RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Sanofi Basic Information, Artemisunate Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Artemisunate Product Portfolios and Specifications
Table 74. Sanofi Artemisunate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Sanofi Main Business
Table 76. Sanofi Latest Developments
Table 77. KPC Pharmaceuticals Basic Information, Artemisunate Manufacturing Base, Sales Area and Its Competitors
Table 78. KPC Pharmaceuticals Artemisunate Product Portfolios and Specifications
Table 79. KPC Pharmaceuticals Artemisunate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. KPC Pharmaceuticals Main Business
Table 81. KPC Pharmaceuticals Latest Developments
Table 82. Guangxi Xiancaotang Pharmaceutical Basic Information, Artemisunate Manufacturing Base, Sales Area and Its Competitors
Table 83. Guangxi Xiancaotang Pharmaceutical Artemisunate Product Portfolios and Specifications
Table 84. Guangxi Xiancaotang Pharmaceutical Artemisunate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Guangxi Xiancaotang Pharmaceutical Main Business
Table 86. Guangxi Xiancaotang Pharmaceutical Latest Developments
Table 87. Guilin Pharmaceutical Basic Information, Artemisunate Manufacturing Base, Sales Area and Its Competitors
Table 88. Guilin Pharmaceutical Artemisunate Product Portfolios and Specifications
Table 89. Guilin Pharmaceutical Artemisunate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Guilin Pharmaceutical Main Business
Table 91. Guilin Pharmaceutical Latest Developments
Table 92. Kerui Nanhai Pharmaceutical Basic Information, Artemisunate Manufacturing Base, Sales Area and Its Competitors
Table 93. Kerui Nanhai Pharmaceutical Artemisunate Product Portfolios and Specifications
Table 94. Kerui Nanhai Pharmaceutical Artemisunate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95. Kerui Nanhai Pharmaceutical Main Business
Table 96. Kerui Nanhai Pharmaceutical Latest Developments
Table 97. Shanghai Natural Bio-engineering Co Basic Information, Artemisunate Manufacturing Base, Sales Area and Its Competitors
Table 98. Shanghai Natural Bio-engineering Co Artemisunate Product Portfolios and Specifications
Table 99. Shanghai Natural Bio-engineering Co Artemisunate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Shanghai Natural Bio-engineering Co Main Business
Table 101. Shanghai Natural Bio-engineering Co Latest Developments
Table 102. Novanat Bioresource Basic Information, Artemisunate Manufacturing Base, Sales Area and Its Competitors
Table 103. Novanat Bioresource Artemisunate Product Portfolios and Specifications
Table 104. Novanat Bioresource Artemisunate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 105. Novanat Bioresource Main Business
Table 106. Novanat Bioresource Latest Developments
Table 107. Botanical Extracts EPZ Ltd Basic Information, Artemisunate Manufacturing Base, Sales Area and Its Competitors
Table 108. Botanical Extracts EPZ Ltd Artemisunate Product Portfolios and Specifications
Table 109. Botanical Extracts EPZ Ltd Artemisunate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Botanical Extracts EPZ Ltd Main Business
Table 111. Botanical Extracts EPZ Ltd Latest Developments
LIST OFFIGURES
Figure 1. Picture of Artemisunate
Figure 2. Artemisunate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artemisunate Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Artemisunate Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Artemisunate Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Artemisunate Sales Market Share by Country/Region (2024)
Figure 10. Artemisunate Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Pharmaceutical Grade
Figure 12. Product Picture of Industrial Grade
Figure 13. Global Artemisunate Sales Market Share byType in 2025
Figure 14. Global Artemisunate Revenue Market Share byType (2020-2025)
Figure 15. Artemisunate Consumed in MalariaTreatment
Figure 16. Global Artemisunate Market: MalariaTreatment (2020-2025) & (MT)
Figure 17. Artemisunate Consumed in Scientific Research
Figure 18. Global Artemisunate Market: Scientific Research (2020-2025) & (MT)
Figure 19. Artemisunate Consumed in Others
Figure 20. Global Artemisunate Market: Others (2020-2025) & (MT)
Figure 21. Global Artemisunate Sale Market Share by Application (2024)
Figure 22. Global Artemisunate Revenue Market Share by Application in 2025
Figure 23. Artemisunate Sales by Company in 2025 (MT)
Figure 24. Global Artemisunate Sales Market Share by Company in 2025
Figure 25. Artemisunate Revenue by Company in 2025 ($ millions)
Figure 26. Global Artemisunate Revenue Market Share by Company in 2025
Figure 27. Global Artemisunate Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Artemisunate Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Artemisunate Sales 2020-2025 (MT)
Figure 30. Americas Artemisunate Revenue 2020-2025 ($ millions)
Figure 31. APAC Artemisunate Sales 2020-2025 (MT)
Figure 32. APAC Artemisunate Revenue 2020-2025 ($ millions)
Figure 33. Europe Artemisunate Sales 2020-2025 (MT)
Figure 34. Europe Artemisunate Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Artemisunate Sales 2020-2025 (MT)
Figure 36. Middle East & Africa Artemisunate Revenue 2020-2025 ($ millions)
Figure 37. Americas Artemisunate Sales Market Share by Country in 2025
Figure 38. Americas Artemisunate Revenue Market Share by Country (2020-2025)
Figure 39. Americas Artemisunate Sales Market Share byType (2020-2025)
Figure 40. Americas Artemisunate Sales Market Share by Application (2020-2025)
Figure 41. United States Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Artemisunate Sales Market Share by Region in 2025
Figure 46. APAC Artemisunate Revenue Market Share by Region (2020-2025)
Figure 47. APAC Artemisunate Sales Market Share byType (2020-2025)
Figure 48. APAC Artemisunate Sales Market Share by Application (2020-2025)
Figure 49. China Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 53. India Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Artemisunate Sales Market Share by Country in 2025
Figure 57. Europe Artemisunate Revenue Market Share by Country (2020-2025)
Figure 58. Europe Artemisunate Sales Market Share byType (2020-2025)
Figure 59. Europe Artemisunate Sales Market Share by Application (2020-2025)
Figure 60. Germany Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 61.France Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Artemisunate Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Artemisunate Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Artemisunate Sales Market Share by Application (2020-2025)
Figure 68. Egypt Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Artemisunate Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Artemisunate in 2025
Figure 74. Manufacturing Process Analysis of Artemisunate
Figure 75. Industry Chain Structure of Artemisunate
Figure 76. Channels of Distribution
Figure 77. Global Artemisunate Sales MarketForecast by Region (2026-2031)
Figure 78. Global Artemisunate Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Artemisunate Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Artemisunate Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Artemisunate Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Artemisunate Revenue Market ShareForecast by Application (2026-2031)
